Islam Md Sadequl, Habib Md Ahsan, Tonu Nasrin Sultana, Haque Md Samiul, Rahman Md Mostafizer
Department of Anatomy and Histology, Faculty of Veterinary and Animal Science, Hajee Mohammad Danesh Science and Technology University, Dinajpur, Bangladesh.
Department of Animal Science and Nutrition, Faculty of Veterinary and Animal Science, Hajee Mohammad Danesh Science and Technology University, Dinajpur, Bangladesh.
Vet Med Sci. 2025 Jan;11(1):e70200. doi: 10.1002/vms3.70200.
Brucellosis is a zoonotic disease caused by Brucella spp., affecting various animals and humans, leading to significant economic and public health impacts. Traditional diagnostic methods, mainly serological, often fail to detect seronegative carriers, which continue to spread the infection.
This review aims to highlight advancements in molecular diagnostics that address these limitations.
A systematic search of PubMed, Web of Science and Scopus was conducted, focusing on studies using seronegative, PCR, qPCR and biosensor-based techniques. Data extraction and meta-analyses were performed, evaluating pooled detection rates and heterogeneity.
Through analysis of existing studies, we review key molecular techniques, including PCR, LAMP and biosensor-based assays, which offer high sensitivity and specificity by detecting bacterial DNA directly, thus overcoming the challenges of antibody-based tests. Meta-analysis of detection rates across different studies showed significant variability, with rates ranging from 0.96% to 100%, highlighting differences in sample types, animal species and regions. The pooled detection proportion from random-effects models was 35.08%, indicating that many seronegative animals still carry Brucella spp. A forest plot analysis further confirmed heterogeneity in detection, underlining the importance of using molecular diagnostics alongside serological tests to identify hidden carriers.
Innovations like nanoparticle-enhanced biosensors and CRISPR-Cas systems show promise for rapid, on-site diagnostics. The findings suggest that integrating molecular methods with traditional serology can improve surveillance and disease management. Future research should focus on developing portable, field-ready diagnostic devices and standardised protocols, along with exploring novel biomarkers to detect latent infections. A collaborative One Health approach, involving veterinary, public health and environmental sectors, is essential for comprehensive disease control and eradication efforts.
布鲁氏菌病是由布鲁氏菌属引起的一种人畜共患病,影响各种动物和人类,对经济和公共卫生造成重大影响。传统诊断方法主要是血清学方法,常常无法检测出血清学阴性携带者,而这些携带者会持续传播感染。
本综述旨在强调解决这些局限性的分子诊断技术进展。
对PubMed、Web of Science和Scopus进行系统检索,重点关注使用血清学阴性、聚合酶链反应(PCR)、实时荧光定量PCR(qPCR)和生物传感器技术的研究。进行数据提取和荟萃分析,评估合并检测率和异质性。
通过对现有研究的分析,我们综述了关键的分子技术,包括PCR、环介导等温扩增技术(LAMP)和基于生物传感器的检测方法,这些技术通过直接检测细菌DNA提供高灵敏度和特异性,从而克服了基于抗体检测的挑战。对不同研究的检测率进行荟萃分析显示出显著差异,检测率从0.96%到100%不等,突出了样本类型、动物种类和地区的差异。随机效应模型的合并检测比例为35.08%,表明许多血清学阴性动物仍携带布鲁氏菌属。森林图分析进一步证实了检测中的异质性,强调了将分子诊断与血清学检测结合使用以识别隐性携带者的重要性。
纳米颗粒增强生物传感器和CRISPR-Cas系统等创新技术在快速现场诊断方面显示出前景。研究结果表明,将分子方法与传统血清学相结合可以改善监测和疾病管理。未来的研究应侧重于开发便携式、可现场使用的诊断设备和标准化方案,同时探索新型生物标志物以检测潜伏感染。一种涉及兽医、公共卫生和环境部门的协作式“同一健康”方法对于全面的疾病控制和根除努力至关重要。